We are live on
!
Find out more
Immuneering
IMRX
IMRX
95 hedge funds and large institutions have $154M invested in Immuneering in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 18
23% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 22
10% more funds holding
Funds holding: 86 → 95 (+9)
3.84% less ownership
Funds ownership: 49.17% → 45.33% (-3.8%)
26% less capital invested
Capital invested by funds: $209M → $154M (-$54.6M)
33% less call options, than puts
Call options by funds: $962K | Put options by funds: $1.43M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
95
Holders Change
+9
Holders Change %
+10.47%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
30
Increased
27
Reduced
22
Closed
18
Calls
$962K
Puts
$1.43M
Net Calls
-$472K
Net Calls Change
-$1.99M
Top Buyers
Top Sellers
| 1 |
EAM
Empery Asset Management
New York
|
-$17.6M |
| 2 |
State Street
Boston,
Massachusetts
|
-$10.9M |
| 3 |
BOCH
Blue Owl Capital Holdings
New York
|
-$4.38M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.09M |
| 5 |
Morgan Stanley
New York
|
-$992K |
